Innate Immune Sensing of Adeno-Associated Virus Vectors
Human Gene Therapy · 2024-07 · 35 (13-14) · 451-463
DOI: 10.1089/hum.2024.040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 17.07.2024. Verfasst von Di Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Dependovirus, Immunity, Innate, Genetic Vectors. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Adeno-associated virus (AAV) based viral vectors are widely used in human gene therapy and form the basis of approved treatments for several genetic diseases. Immune responses to vector and transgene products, however, substantially complicate these applications in clinical practice. The role of innate immune recognition of AAV vectors was initially unclear, given that inflammatory responses early after vector administration were typically mild in animal models. However, more recent research continues to identify innate immune pathways that are triggered by AAV vectors and that serve to provide activation signals for antigen-presenting cells and initiation of adaptive immune responses. Sensing of the AAV genome by the endosomal DNA receptor toll-like receptor 9 (TLR9) promotes early inflammatory response and interferon expression. Thus, activation of the TLR9>MyD88 pathway in plasmacytoid dendritic cells (pDCs) leads to the conditioning of antigen cross-presenting DCs through type I interferon (IFN-I) and ultimately CD8 + T cell activation. Alternatively, pDCs may also promote CD8 + T cell responses in a TLR9-independent manner by the production of IL-1 cytokines, thereby activating the IL-1R1>MyD88 signaling pathway. AAV can induce cytokine expression in monocyte-derived DCs, which in turn increases antibody formation. Binding of AAV capsid to complement components likely further elevates B cell activation. At high systemic vector doses in humans and in non-human primates, AAV vectors can trigger complement activation, with contributions by classical and alternative pathways, leading to severe toxicities. Finally, evidence for activation of TLR2 by the capsid and of additional innate receptors for nucleic acids has been presented. These observations show that AAV vectors can initiate several and likely redundant innate immune pathways resulting in an exaggerated adaptive immune response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, Indiana, USA.
- Department of Pediatrics, University of Florida, Gainesville, Florida, USA.
- Division of Gastroenterology & Hepatology, Weill Cornell Medicine, New York, New York, USA.
- Division of Immunology, Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, USA.
- Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
ORCID-Profile: Roland W Herzog
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Cao, D., Byrne, B. J., de Jong, Y. P., Terhorst, C., Duan, D., Herzog, R. W., & Kumar, S. R. P. (2024). Innate Immune Sensing of Adeno-Associated Virus Vectors. Human Gene Therapy, 35(13-14), 451-463. https://doi.org/10.1089/hum.2024.040
Vancouver
Cao D, Byrne BJ, de Jong YP, Terhorst C, Duan D, Herzog RW, et al. Innate Immune Sensing of Adeno-Associated Virus Vectors. Human Gene Therapy. 2024;35(13-14):451-463. doi:10.1089/hum.2024.040
BibTeX
@article{Cao2024,
author = {Cao, Di and Byrne, Barry J and de Jong, Ype P and Terhorst, Cox and Duan, Dongsheng and Herzog, Roland W and Kumar, Sandeep R P},
title = {Innate Immune Sensing of Adeno-Associated Virus Vectors},
journal = {Human Gene Therapy},
year = {2024},
volume = {35},
number = {13-14},
pages = {451--463},
doi = {10.1089/hum.2024.040}
}
EUVIMED